Skip to main content
All lobbying clients

PFIZER, INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical manufacturing.

$26,880,000 Reported spend
85 Filings counted
13 Outside firms hired
41 Bills named

Spend is reported income plus in-house expenses across 85 filings. 10 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 14 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as PFIZER, PFIZER INC, PFIZER INC., PFIZER, INC.

 Who filed for this client 14

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings top 30 of 41
  • H.R. 1
    One Big Beautiful Bill Act
    11 filings
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    11 filings
  • S. 1040
    Drug Competition Enhancement Act
    10 filings
  • S. 1041
    Affordable Prescriptions for Patients Act
    10 filings
  • H.R. 2214
    DRUG Act
    7 filings
  • H.R. 5509
    Safe Step Act
    5 filings
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    4 filings
  • H.R. 1062
    Growing and Preserving Innovation in America Act of 2025
    4 filings
  • H.R. 1990
    American Innovation and R&D Competitiveness Act of 2025
    4 filings
  • H.R. 1347
    AIMM Act
    3 filings
  • H.R. 5256
    340B ACCESS Act
    3 filings
  • S. 1639
    American Innovation and Jobs Act
    3 filings
  • S. 1688
    Growing America’s Small Businesses and Manufacturing Act
    3 filings
  • S. 559
    AIMM Act
    3 filings
  • H.R. 5178
    Sickle Cell Disease Comprehensive Care Act
    2 filings
  • H.R. 7837
    Most Favored Patient Act of 2026
    2 filings
  • H.R. 9102
    BINSA Act
    2 filings
  • H.R. 946
    ORPHAN Cures Act
    2 filings
  • S. 2903
    Safe Step Act
    2 filings
  • S. 3510
    Biosimilar Inspection Modernization Act of 2025
    2 filings
  • S. 832
    EPIC Act of 2025
    2 filings
  • H.R. 574
    Earned Income and Child Tax Credits Outreach Act of 2021
    1 filing
  • H.R. 2882
    Further Consolidated Appropriations Act, 2024
    1 filing
  • H.R. 2213
    Medical Supply Chain Resiliency Act
    1 filing
  • H.R. 2450
    Prescription Drug Transparency and Affordability Act
    1 filing
  • H.R. 4101
    Cancer Drug Parity Act of 2025
    1 filing
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    1 filing
  • H.R. 4317
    PBM Reform Act of 2025
    1 filing
  • H.R. 4581
    340B PATIENTS Act of 2025
    1 filing
  • H.R. 4930
    To expand the sharing of information with respect to suspected violations of intellectual property rights in …
    1 filing
 Reported by year 2 years
  • 2026 $11,880,000 36 filings
  • 2025 $15,000,000 49 filings
 Issues lobbied 10

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 16
  • HOUSE OF REPRESENTATIVES 65
  • SENATE 63
  • Health & Human Services, Dept of (HHS) 29
  • Centers For Medicare and Medicaid Services (CMS) 25
  • Food & Drug Administration (FDA) 12
  • Executive Office of the President (EOP) 10
  • White House Office 8
  • Commerce, Dept of (DOC) 7
  • Natl Economic Council (NEC) 7
  • U.S. Trade Representative (USTR) 7
  • Treasury, Dept of 6
  • Federal Trade Commission (FTC) 2
  • Natl Institutes of Health (NIH) 2
  • State, Dept of (DOS) 2
  • Centers For Disease Control & Prevention (CDC) 1
  • Substance Abuse & Mental Health Services Administration (SAMHSA) 1
 Recent filings 95 total
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
THE DUBERSTEIN GROUP INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
WILLIAMS AND JENSEN, PLLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
PFIZER INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $3,600,000 expenses · posted Oct 20, 2026
View →
Q3 report
MILLER STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · $150,000 income · posted Oct 20, 2026
View →
Q3 report
FEDERAL HEALTH POLICY STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
BGR GOVERNMENT AFFAIRS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2026 (July 1 - Sep 30) · $50,000 income · posted Oct 20, 2026
View →
Q3 report
RESOLUTION PUBLIC AFFAIRS, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
THE WASHINGTON TAX & PUBLIC POLICY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 16, 2026
View →
Q3 reportNo activity
ALTRIUS GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 13, 2026
View →
Q1 amendment
PFIZER INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $4,430,000 expenses · posted Oct 7, 2026
View →
Q4 amendment
PFIZER INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $1,790,000 expenses · posted Aug 3, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
WILLIAMS AND JENSEN, PLLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
MILLER STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $150,000 income · posted Jul 20, 2026
View →
Q2 report
PFIZER INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,880,000 expenses · posted Jul 20, 2026
View →
Q2 report
THE WASHINGTON TAX & PUBLIC POLICY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 20, 2026
View →
Q2 report
FEDERAL HEALTH POLICY STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 95 filings. Search the explorer for "PFIZER, INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem